Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Debt (2022 - 2025)

Rxo (RXO) has disclosed Total Debt for 4 consecutive years, with $404.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 9.78% year-over-year to $404.0 million, compared with a TTM value of $404.0 million through Dec 2025, up 9.78%, and an annual FY2025 reading of $404.0 million, up 9.78% over the prior year.
  • Total Debt was $404.0 million for Q4 2025 at Rxo, roughly flat from $403.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $455.0 million in Q4 2022 and bottomed at $11.0 million in Q3 2022.
  • Average Total Debt over 4 years is $377.9 million, with a median of $403.0 million recorded in 2025.
  • Peak annual rise in Total Debt hit 4027.27% in 2023, while the deepest fall reached 21.1% in 2023.
  • Year by year, Total Debt stood at $455.0 million in 2022, then fell by 21.1% to $359.0 million in 2023, then rose by 2.51% to $368.0 million in 2024, then rose by 9.78% to $404.0 million in 2025.
  • Business Quant data shows Total Debt for RXO at $404.0 million in Q4 2025, $403.0 million in Q3 2025, and $403.0 million in Q2 2025.